Serial biotech entrepreneur and Harvard professor Greg Verdine is now a venture artner in Ge Li’s  WuXi Healthcare Ventures.

 “There are extraordinary opportunities for biotech companies to team up with entities in the Asia-Pacific region,” Verdine says.

“My main interest in terms of future investment and company-building lies in next-generation therapeutics. “WuXi Healthcare Ventures offers me an internationally-oriented platform from which to launch multiple new companies focused in this space.”